Kim AS, Taylor VE, Castro-Martinez A, Dhakal S, et al. Early and multiple doses of zoledronate mitigates rebound bone loss following withdrawal of RANKL inhibition. J Bone Miner Res 2025 Jan 23:zjaf008. doi: 10.1093.
PMID: 39846954